Glycemic Control
Semaglutide
$360.00 ~
Wegovy 1mg Flextouch Pen is a once-weekly, prefilled subcutaneous injection containing semaglutide,...
Wegovy 1mg Flextouch Pen is a once-weekly, prefilled subcutaneous injection containing semaglutide, a long-acting GLP-1 receptor agonist specifically approved for the treatment of obesity. By mimicking endogenous glucagon-like peptide-1, it regulates multiple metabolic pathways, including enhancing insulin secretion (when blood glucose is elevated), suppressing glucagon, and delaying gastric emptying. These mechanisms work synergistically to reduce appetite, prolong satiety, and decrease overall caloric intake. While semaglutide is used off-label for type 2 diabetes control in some formulations, Wegovy is not approved for glycemic management and must be used exclusively as a weight loss therapeutic. This 1mg dose represents an intermediate step in the titration protocol, preparing patients for the final maintenance dose of 2.4mg.
Show more